Laura Canzi

Summary

Affiliation: Istituto Nazionale Neurologico Carlo Besta
Country: Italy

Publications

  1. pmc Human skeletal muscle stem cell antiinflammatory activity ameliorates clinical outcome in amyotrophic lateral sclerosis models
    Laura Canzi
    Department of Cerebrovascular Disease, IRCCS Foundation, Neurological Institute C Besta, Milan, Italy
    Mol Med 18:401-11. 2012
  2. pmc Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential
    Antonella Blasi
    Cellular Neurobiology Laboratory, Department of Cerebrovascular Diseases, Fondazione IRCCS Neurological Institute Carlo Besta, 20133 Milan, Italy
    Vasc Cell 3:5. 2011
  3. ncbi request reprint Nanotechnology advances in brain tumors: the state of the art
    Gloria Invernici
    Cellular Neurobiology Laboratory, UO Cerebrovascular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
    Recent Pat Anticancer Drug Discov 6:58-69. 2011
  4. ncbi request reprint Stem cell patents: an innovative approach to anti-cancer drug discovery
    Stefania Navone
    Cellular Neurobiology Laboratory, UO Cerebrovascular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
    Recent Pat Anticancer Drug Discov 5:14-21. 2010

Collaborators

Detail Information

Publications4

  1. pmc Human skeletal muscle stem cell antiinflammatory activity ameliorates clinical outcome in amyotrophic lateral sclerosis models
    Laura Canzi
    Department of Cerebrovascular Disease, IRCCS Foundation, Neurological Institute C Besta, Milan, Italy
    Mol Med 18:401-11. 2012
    ....
  2. pmc Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential
    Antonella Blasi
    Cellular Neurobiology Laboratory, Department of Cerebrovascular Diseases, Fondazione IRCCS Neurological Institute Carlo Besta, 20133 Milan, Italy
    Vasc Cell 3:5. 2011
    ..abstract:..
  3. ncbi request reprint Nanotechnology advances in brain tumors: the state of the art
    Gloria Invernici
    Cellular Neurobiology Laboratory, UO Cerebrovascular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
    Recent Pat Anticancer Drug Discov 6:58-69. 2011
    ..The latest advances in both the research sector and in recent patents for cancer imaging and therapy are discussed...
  4. ncbi request reprint Stem cell patents: an innovative approach to anti-cancer drug discovery
    Stefania Navone
    Cellular Neurobiology Laboratory, UO Cerebrovascular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
    Recent Pat Anticancer Drug Discov 5:14-21. 2010
    ..Over one third of all stem cell applications and one quarter of all embryonic stem cell applications have been granted. The aim of this review is primarily to focus on the recent development of stem cell patents in cancer treatments...